Health
China’s Covid-19 vaccine candidate proves safe in initial tests – Hindustan Times
Scientists have said that despite the vaccine proving safe, no data to establish the final efficacy.
Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under human trial observation, has safely triggered the expected antibody immune responses.
The combined early and mid-stage trials for the vaccine happened between April 29 and July 30 this year.
Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), is currently developing the vaccine. It is one of ten potential vaccine candidates that have entered the Phase III trials around the …
-
Noosa News23 hours agoHow a 3D printed aorta helped surgeons replace a ‘ticking time bomb’ inside a man’s chest
-
Noosa News20 hours agoEnsure voices are heard – Proctor
-
Noosa News22 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General22 hours agoReserve Bank board still looking for yesterday’s news